clinical trial · NCT03189641
Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions
JIMRO Co., Ltd.·N/A·completed·n = 30
Coronary Artery DiseaseCilostazol eluting stent system (CES-1)
brief summary
The purpose of the this trial is to evaluate the clinical safety and efficacy of Cilostazol eluting stent system (CES-1) for the treatment of single de novo lesions in native coronary arteries.
started
May 31, 2017
primary completion
Mar 27, 2020
completion
Jul 26, 2024
last updated
Mar 14, 2025
official title
An Exploratory Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol